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Abstract 
Background: Compelling evidence has been accumulated to support the effectiveness of intensive lifestyle inter‑
vention in delaying progression to Type 2 diabetes even in people identified as being at high risk determined by the 
Finnish diabetes risk score. The DE‑PLAN‑CAT project (diabetes in Europe‑prevention using lifestyle, physical activity 
and nutritional intervention–Catalonia) evidenced that intensive lifestyle intervention was feasible and cost‑effective 
on a short scale in real‑life primary care settings, at least over 4 years. However, transferring such lifestyle interventions 
to society remains the major challenge of research in the field of diabetes prevention.
Methods/design: The derived DP‑TRANSFERS (diabetes prevention‑transferring findings from European research to 
society) is a large scale national programme aimed at translating a tailored lifestyle intervention to the maximum of 
primary care centres where feasible through a core proposal agreed with all the partners. The method is built upon 
a 3‑step (screening, intervention and follow‑up) real‑life, community‑wide structure on the basis of a dual intensity 
lifestyle intervention (basic and continuity modules) and supported by a 4‑channel transfer strategy (institutional 
relationships, facilitators’ workshops, collaborative groupware and programme WEB page). Participation will initially 
cover nine health departments (7 million inhabitants) through nine coordinating centres located in metropolitan (3.2 
million), semi‑urban (2.9 million) and rural (0.9 million) areas from which it is expected accessing 25 % of all primary 
care settings, equivalent to 90 associated centres (1.6–1.8 million people) with an estimate of 0.32 million participants 
aged 45–75 years at high risk of future development of diabetes. To ascertain sustainability, effect, satisfaction and 
quality of the translation programme statistical analyses will be performed from both the entire population (facilita‑
tors and participants) and a stratified representative sample obtained by collecting data from at least 920 participants.
Discussion: The DP‑TRANSFERS will use a strategy of approach to society consistent with the impact of the disease 
and the fast accessibility provided by primary care settings in Catalonia. Both the widespread effect of the lifestyle 
intervention and the translational process itself could be assessed.
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Background
Type 2 diabetes is a serious public health problem in con-
tinuous increasing during the past decades. The risk fac-
tors for the disease are closely related to lifestyle, which 
is partly an effect of personal choices but also a result of 
built environment, physical and social background, cul-
ture, and socio-economic issues. The most relevant risk 
factors are obesity, sedentary lifestyle, and unhealthy diet. 
Therefore, the main drivers of the current epidemic level 
are increasing obesity—leading to more people develop-
ing diabetes during their life-course—and population 
aging, with more people living longer with impaired glu-
cose metabolism [1].
The notion that diabetes development can be prevented 
or delayed by intensive lifestyle intervention is not new 
[2–4]. Since 2007 the International Diabetes Federation 
recommends a stepwise approach starting with identifi-
cation of those who may be at higher risk, following with 
the measurement of current risk and finally, delivering an 
appropriate intervention [5]. In terms of public health, 
these theoretical statements would only be sustainable if 
it really could be first tailored to the specific local situ-
ation and then transferred to clinical practice, particu-
larly in primary health care [6]. In fact, it has recently 
been suggested that progression to diabetes can be also 
delayed by intensive intervention when applied to real-
life primary health care of high-risk subjects identified 
first with the simple Finnish diabetes risk score (FIND-
RISC) tool [7].
Despite some controversy [8], it is commonly accepted 
that a well designed and implemented programme on 
diabetes prevention is more effective (and even more 
cost-effective) than doing nothing. Undoubtedly, the effi-
ciency may vary depending on the wealth of the partici-
pants but also on their dietary habits and the ability of 
an intervention to significantly reduce weight [9]. Recent 
results from Finland have shown that diabetes can be 
postponed in average by 5  years in people who already 
have impaired glucose regulation [10]. Even if we could 
not prevent the development of diabetes, just delaying 
the disease to later life might have a large impact both on 
individual and on societal level.
Translational actions are those applying the knowledge 
from research to clinical practice. Regarding diabetes 
prevention, any strategy intended at national level should 
be feasible, effective and efficient, issues that should be 
evidenced in advance. This was the original background 
of the international European DE-PLAN project (diabe-
tes in Europe-prevention using lifestyle, physical activity 
and nutritional intervention) [11] in which the Catalan 
research associated group (DE-PLAN-CAT) reached to 
ascertain long-term feasibility, effectiveness and 
cost-effectiveness of the lifestyle intervention at national 
level [12, 13].
The project was conducted in 18 primary care centres 
with an optimum positive response rate (greater than 
82  %) for both screening (n  =  2054) and intervention 
(n = 552). The overall incidence of diabetes was reduced 
by 36.5  % at 4-year follow-up in participants receiving 
the intensive intervention compared to the standard care 
regime [12]. Additionally, a convenient cost-effectiveness 
ratio (3243 € per QALY gained) could be clearly shown 
[13]. Similarly to most well designed clinical and imple-
mentation programmes, the DE-PLAN-CAT used tra-
ditional lifestyle intervention modes such as individual 
and group counselling [14, 15]. Indeed, this model may 
be really feasible and cost-effective on a short scale in 
primary care, but if the number of participants (interven-
tion exposure) is low, a high effect on the community as 
a whole should not be expected. Following the steps pro-
vided for this national programme, a set of translational 
actions were planned in order to involve those Catalan 
primary care centres who agree to participate.
The rising DP-TRANSFERS (diabetes prevention-
transferring findings from European research to society) 
project was defined and structured as a translational 
programme aimed at transferring the DE-PLAN-
CAT knowledge, methodology, didactic materials and 
results—if feasible—to daily clinical practice in primary 
health care. Both the widespread effect of such lifestyle 




Transferring a cost-effective strategy in delaying progres-
sion to Type 2 diabetes among high-risk Mediterranean 
individuals (DE-PLAN-CAT) is also feasible on a large 




The primary objective is to asses the feasibility and effect 
of the DE-PLAN-CAT intensive lifestyle intervention 
when translating into society through a central process of 
dissemination agreed with the primary care centres.
Secondary operational objectives
(a) To establish, expand and reinforce a multidiscipli-
nary Steering Committee with representatives from 
primary care coordinating centres (at least one of each 
health department involved) to implement a single com-
mon translational protocol as well as a curriculum for 
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the training of prevention managers (nurses and general 
practitioners).
(b) To identify needs, design and adapt the DE-PLAN-
CAT intensive lifestyle intervention to the structural 
conditions in primary care settings determinants of the 
real-life clinical practice interventions which are associ-
ated with and could predict a beneficial outcome.
(c) To develop a specific set of easily accessible didac-
tic material for such lifestyle intervention (presentations, 
information sheets and feed-back exercises) in conven-
tional and digital format, from own files but also from 
European projects on diabetes prevention in which the 
Catalan group is associated.
(d) To assess the sustainability and quality of transla-
tion process through the evaluation of the resources 
(balance and cost), the actions (intervention effect) and 
the opinion of the target population (facilitators and 
participants).
Study design
The project does not have a conventional design since it 
is a sequential and coordinated set of actions to be per-
formed in primary care in order to achieve a reasonably 
effective translation of the DE-PLAN-CAT lifestyle inter-
vention using the available resources efficiently.
Setting
The original DE-PLAN-CAT project was performed in 18 
primary health-care centres (Catalan Health Institute). 
The derived DP-TRANSFERS programme will translate a 
tailored lifestyle intervention to the maximum of primary 
care centres where feasible.
Procedure and sample size calculation
The sample size calculation details concerning feasibil-
ity and cost-effectiveness of the DE-PLAN-CAT have 
been published previously [12, 13]. Participation in the 
DP-TRANSFERS will initially cover nine public health 
departments (reference population: 7 million inhabit-
ants) through nine coordinating centres located in met-
ropolitan (3.2 million), semi-urban (2.9 million) and rural 
(0.9 million) areas (http://www.gencat.cat/ics/usuaris/
centres_serveis.htm). The programme aims to involve 
the largest number of participants (subjects at diabetes 
risk) as possible. However, only data from a representa-
tive sample of participants will be used for evaluating 
the translation process and the results. The proposal for 
participation will be first agreed with the managers and 
staff of primary care centres. Thus, considering a tree 
structure starting from each coordinating centre, the new 
participating ones (associated centres) will be invited in 
a stratified manner following a representative geographic 
distribution as well as particular responsibilities within 
the health system (Fig. 1).
The maximum level of participation is determined by 
a total of 369 pre-existing centres, 334 (90  %) ascribed 
to the Catalan Health Institute who attended 4.2 mil-
lion people during the last year 2014 [16]. Assuming that 
involving all these centres simultaneously would be inef-
fective, the Steering Committee approved expanding life-
style intervention to a 25 % of the primary care centres in 
order to have a significant impact on the whole commu-
nity in 3 years (1 year for the screening step and 2 years 
for the intervention step). Regarding a progressive shift-
ing process, it is expected to involve at least 5 % of new 
centres during the first year of programme implementa-
tion and not less than 20 % over the next 2 years which 
would mean a total of 90 primary care centres (reference 
population: 1.6–1.8 million inhabitants and, hypotheti-
cally, 0.32 million classified as having diabetes risk by the 
FINDRISC).
Although the effectiveness of the lifestyle interven-
tion is already proven, an effort will be made to ascertain 
sustainability and quality of the translation process. For 
this purpose, statistical analyses will be performed from 
a stratified sample. As for the risk screening step, data 
entry will be restricted to the 5, 10 and 15 first consecu-
tive participants with positive screening invited to receive 
the intervention, on the basis of three strata: rural (<5000 
inhabitants), semi-urban (5000–10,0000) and metropoli-
tan (>100,000). Similarly for the intervention step, base-
line and 2-year follow-up data entry will be restricted to 
the 5, 10 and 15 first consecutive participants who ulti-
mately accept to receive the lifestyle intervention.
Thus, accepting a proportional sample distribution of 
the attended population within these strata and allowing 
a two-year discontinuation rate close to 20 % (similar to 
that found in the DE-PLAN-CAT study), it is expected 
collecting data from at least 920 participants in the 
screening (118 rural, 381 semi-urban, 421 metropolitan) 
and 736 participants in the subsequent lifestyle inter-
vention to test feasible and effective ways for assessing 
diabetes risk, delivering the intervention and providing 
support to maintain successful behavioural changes (sta-
tistical power 82.5 %; type 1 and type 2 errors 5 and 20 %, 
respectively).
Methods and participants
Facilitator level (health professionals)
The working method of the DE-PLAN-CAT public health 
study will be used for the translational programme pur-
poses [12]. Additionally, the multidisciplinary Steering 
Committee has been reinforced to implement the DP-
TRANSFERS initiative with representatives from each 
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coordinating centre (nurses and general practitioners), 
epidemiologists, dieticians and experts in facilitating 
health interventions within a community setting. This 
coordinating group will be also shared by executive staff 
of the leading providers of public health services, techni-
cians of the government agency (Department of Health) 
and also by relevant members from primary care scien-
tific societies. The current priority is to translate the DE-
PLAN-CAT compelling experience into clinical solutions 
by supporting first a 3-year, 3-stage transfer procedure 
(Fig.  2). The three stages designed include: (a) Involve-
ment of primary care teams already working on diabetes 
prevention; (b) Involvement of the rest of primary care 
teams who have not previously participated in tasks spe-
cifically related to diabetes prevention in those centres; 
(c) Involvement of new teams operating in other primary 
care centres with the common characteristic of never 
having participated in regulated projects aimed at pre-
venting diabetes.
The translation process will be conducted through four 
channels or strategies (Fig. 2): (a) Specific website which 
will also include an electronic case report form (eCRF) 
for data collection; (b) Face-to-face workshops for facili-
tators prior to the start of any intervention. Members of 
the Steering Committee will widely inform on the pro-
gramme, delivery rules, training tools and evaluation cri-
teria; (c) Administrative structures of each institution will 
be linked and implemented; (d) High technologies, vide-
oconferencing and collaborative groupware will be used 
for information exchange. A persuasive internet-based 
interactive system to facilitate self-monitored interven-
tion is also planned but would be part of a second phase 
as well as translation towards built environment (munici-
palities, workplaces, pharmacies and non-governmental 
organizations) trying to promote screening actions, phys-
ical activity and healthy diet.
The method of transferring the intervention will 
include assistance in increasing participant’s motivation 
Fig. 1 Geografical distribution of the DP‑TRANSFERS coordinating centres at the start of the programme; The colour intensity is proportional to the 
absolute density of population per county within the Catalan territory
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to change lifestyle, planning actions and promoting per-
sistence over time. Changing behaviour is a complex 
process but it is acknowledged that simply disseminat-
ing information about recommended lifestyle is not 
enough. Recently there has been a shift in diabetes pre-
vention rules, increasing the use of techniques that facili-
tate empowerment—the participants no longer being 
“subjects” of the intervention but equal partners, taking 
charge of their own way of life. Facilitators may help the 
process by making questions, suggestions and support-
ing the change. These will be the key messages introduc-
ing nine kick-off training meetings for facilitators to be 
organized in each coordinating centre.
Design of lifestyle intervention will be conducted by 
the Steering Committee, particularly nursing. Follow-
ing the recommendations of the European guideline 
and training standards for diabetes prevention panel, 
the intervention has been raised in two levels [17]. First, 
an individual level for personal goal setting, maintain 
motivational support and ways to solve relapses. Sec-
ondly, a group intervention is required to consolidate the 
changes in habits and behaviours thereby trying to delay 
disease progression. The contents of the group sessions 
will be clearly addressed through an understandable lan-
guage and positive messages. The method should be as 
participatory as necessary to involve the attendees from 
the start of each session.
The core intervention materials (identical for each 
participating centre) will be provided centrally to all 
facilitators. The axis of every session consists of a slide 
set, activity sheets and homework tasks for participants 
as well as teaching and introductory material for facili-
tators. Other local equipment may be used as long as 
they are in line with the DP-TRANSFERS intervention 
goals. Every group session shall cover relevant aspects 
of diabetes and cardiovascular risk prevention and espe-
cially are thought to encourage a healthy relationship 
towards eating and exercising. The dietary intervention 
will focus on the healthy Mediterranean diet pattern 
promoting consumption of omega-3 and monounsatu-
rated fatty acids [18]. The physical activity intervention 
will be based on information synthesis and training, if 
feasible.
Participant level (subjects at diabetes risk)
Among all users of public primary health care services, 
the target population for the programme corresponds to 
people without a diagnosis of Type 2 diabetes between 
the ages of 45 and 75 years, having either or both of the 
two following conditions:
Fig. 2 DP‑TRANSFERS chronogram and strategy steps. PHCT primary health care team, PHCC Primary Health Care Centre, DE‑PLAN‑CAT (diabetes 
prevention program project)
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(1)  Diabetes risk suggested by a FINDRISC > 11
(2)   Prediabetes diagnosis as defined by the World 
Health Organization diagnostic criteria [19], 
based on previous (last year) or current (screen-
ing time) laboratory reports:
(a) Impaired fasting glucose (IFG): fasting 
plasma glucose (FPG) greater or equal than 
6.1 and less than 7.0 mmol/l.
(b) Impaired glucose tolerance (IGT): FPG less 
than 7.0 mmol/l and 2 h- postload glucose 
(2hPG) in the 2-h 75-g Oral Glucose Tol-
erance Test (OGTT) greater or equal than 
7.8 mmol/l and less than 11.1 mmol/l.
(c) IFG plus IGT (both diagnostic categories 
simultaneously).
All individuals with severe psychiatric disease or seri-
ous disorders that could influence the screening or 
induce discontinuation of the intervention should be 
excluded at the discretion of facilitators.
The whole programme will be translated and should be 
integrated into daily clinical practice of the participating 
primary care centres. The main pre-requisite is the prac-
tice having a computerized patient record system. Poten-
tial participants can be contacted by letter, telephone or 
otherwise for a first evaluation. If the centre has already 
an ongoing strategy for diabetes prevention, computer-
ized clinical records could be reviewed searching for DP-
TRANSFERS eligible participants.
The research ethics committee board at the Jordi Gol 
Research Institute (Barcelona) approved the protocol 




Opportunistic screening will be the main route of 
entry into the programme. An advance search from the 
computerized records of the public health system has 
been recommended to select potential candidates for 
screening.
The first screen option will use the Catalan and Spanish 
versions of the FINDRISC, a well-validated, eight-item 
European questionnaire related to diabetes risk factors 
to characterize subjects according to their future risk of 
Type 2 diabetes. The feasibility and performance of this 
test have been widely assessed in our country [20, 21]. 
The most recent version will be the one used, and ranged 
from 0 to 26 points, as follows: <7 points (low), 7 to 11 
(slightly increased), 12 to 14 (moderate), 15 to 20 (high), 
and over 20 (very high) [10]. The questionnaire col-
lected information about age, sex, weight and height (to 
calculate body mass index), waist circumference, use of 
blood-pressure medication, history of high blood glucose 
disorders, physical activity, family history of diabetes, 
and daily consumption of vegetables, fruits and berries.
The second screen option refers to the use of previous 
(last year) or current (screening time) laboratory reports. 
This option may involve but are not limited to the FPG 
measurement—the most commonly used in routine 
clinical practice—since the standardized 2-h 75-g OGTT 
(along with measurements of FPG and 2hPG) has been 
also accepted according to the real possibilities of devel-
opment in the participating centres. For this part of the 
DP-TRANSFERS programme (screening), diagnosis of all 
glucose disorders will be based on the results of a single 
test.
Any potential candidate with either a FPG or 2hPG 
result suggestive of diabetes will be excluded from par-
ticipation in the subsequent part of the programme 
(lifestyle intervention). A second test to confirm the diag-
nosis of diabetes has been recommended for those indi-
viduals who ultimately participate in the intervention and 
the follow-up.
Lifestyle intervention step
People will be eligible for the lifestyle intervention only 
if they did not have diabetes and have either or both of 
a FINDRISC score >11 or the diagnosis of prediabetes 
defined by the WHO criteria. All eligible participants 
with positive screening will be offered the intensive life-
style intervention which will be usually provided by 
trained nursing staff. The intervention goals will be simi-
lar to those that were recommended by the European 
DE-PLAN–IMAGE experts’ panel in accordance with 
the Finnish diabetes prevention study [15, 17]. Thus, the 
five targets will be: (a) No more than 30 % of daily energy 
from fat, if feasible; (b) No more than 10 % of energy from 
saturated fat; (c) At least 3.6 g/1000 kJ (15 g/1000 kcal) of 
fibre: (d) At least 30 min/day of moderate physical activ-
ity and (e) 5  % weight reduction (a more realistic 3  % 
could also be acceptable).
The 2-year DP-TRANSFERS lifestyle intervention 
will consist of a synchronous 4 individual counselling 
sessions and 16 group sessions planned in two differ-
ent intensities. The core of the group intervention is a 
9-h basic module including the first six sessions—to be 
delivered during 2  months—in groups of 5–15 partici-
pants who should also receive specific training materials. 
A subsequent 15-h continuity module with the remain-
ing ten sessions—to be delivered during 22 months—will 
complete the scheduled intervention (Table 1).
The method for the basic module will be adapted 
to the experience, needs and skills available based on 
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motivation, peer-support and positive feedback. The fol-
lowing contents have been programmed: (a) What Type 
2 diabetes is and what it means to be at risk; (b) Weight 
management; (c) The Mediterranean diet: nutritional 
advice based on the “Prevención con Dieta Mediter-
ránea”–Mediterranean Diet Adherence Screener (PRED-
IMED–MEDAS) questionnaire as a tool to increase 
adherence during the follow-up [22]; (d) Physical activ-
ity and its beneficial health effects; (e) Eating control 
with relapse management and (f ) Stress management 
and tobacco advice (centres that include smokers in the 
intervention group). The nursing staff taking over the 
basic module will have a checklist available for the group 
sessions giving objectives, a brief description of the ses-
sion including the topics, activity listing, and homework 
listing.
The method for the continuity module will be focused 
on maintaining motivation for preventive lifestyle 
changes by regular group follow-up counselling sessions 
with an approximate frequency of one session every 
2  months (Table  1). In addition, periodic contacts by 
phone or text message will be allowed. One major objec-
tive is to repeat the most important lessons from first six 
sessions sharing experiences from the basic module and 
also expanding educational contents as far as possible: (a) 
Attentive eating; (b) Energy content of food; (c) Learned 
hunger reactions and acquired habits; (d) Different types 
of carbohydrates, lipids and proteins and (e) Expanding 
concepts on physical activity.
The sessions of this module will be associated with 
individual visits for goal setting and to follow the pro-
gress. The facilitator may also use the programme ques-
tionnaires as basis of the conversation and goal-making 
process, if applicable. Process-based evaluation of the 
individual risk and response must be provided to encour-
age the lifestyle modification.
Measuring instruments, outcome measures 
and evaluation
The evaluation of the programme will focus on three 
main aspects: (a) Impact on clinical and behaviour indi-
cators commonly associated with a decreasing in diabetes 
risk; (b) Programme sustainability by assessing process 
carried out (operational objectives, outputs, outcomes 
and deliverables) and (c) Economic analysis of direct 
costs incurred by the implementation of the programme.
For evaluation purposes, a set of measurements will be 
applied either to the entire participant population or a 
representative sample through 4 individual visits sched-
uled at 0, 2, 12 and 24 months in view of detecting par-
ticipants’ baseline status and possible future changes. 
During visits, neither feedback nor comments (positive 
or negative) on the answers will be given. Preferably, the 
checking should not be done by the facilitator, as the par-
ticipant may adapt their answers to look more favourable 
than the true behaviour.
Clinical parameters to be considered and health profile 
instruments to be used could be summarized as follows 
(Table 1).
Impact on clinical and behaviour indicators
Evaluation of lifestyle habits
Through three short, well-validated questionnaires: the 
FINDRISC, the 7-item International Physical Activ-
ity Questionnaire (IPAQ) [23] and the 14-item PRED-
IMED tool (adherence to a Mediterranean diet) [22]. 
Table 1 Technical development of the DP-TRANSFERS lifestyle intervention
FINDRISC Finnish diabetes risk score, eCRF electronic case report form, S group sessions, MEDAS Mediterranean diet adherence screener (from PREDIMED study), IPAQ 
7-item international physical activity questionnaire, EQ-5D-5L 5-item preference-based health-related quality of life instrument
Chronogram (months) 0 2 12 24
FINDRISC assessment X
Anthropometric data X X X X
Laboratory test X X X X
Informed consent X
eCRF data entry X X X X
Individual intervention X X X X
Group intervention S (1–6) S7 S8 S9 S10 S11 S12 S13 S14 S15 S16
Sessions’ assistance X X X
MEDAS questionnaire X X X
IPAQ questionnaire X X X
EQ‑5D‑5L questionnaire X X X
Satisfaction questionnaire  X X X
Intervention step/module Screening Basic Continuity (first year) continuity (second year) 
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Additional questions on socio-demographic characteris-
tics, concomitant diseases and medications, toxic habits 
and social support will be asked at the baseline, 12 and 
24 month.
Non‑invasive clinical and anthropometric measurements
Weight, height, waist circumference, blood pressure and 
heart rate will be measured and recorded using standard 
methods as a part of routine clinical practice in primary 
care.
Biological measurements
Specifically monitoring glucose-related parameters (FPG, 
2h-PG, HbA1c) and lipid profile, particularly serum cho-
lesterol and fractions, would be highly recommended 
depending on the real possibilities of each participating 
centre. These measurements will be repeated at the yearly 
follow-up visits to ascertain Type 2 diabetes incidence. It 
will be emphasized that programmed biological measure-
ments should not increase the burden of laboratory tests 
rather they should be part of routine practice in primary 
care.
Psychological and quality of life measurements
Prior to any intervention, the participants must complete 
a minimal survey focused on individual self-reported 
interest in introducing lifestyle changes. Quality of life 
will be assessed using a 5-item preference-based health-
related quality of life instrument EQ-5D-5L, a stand-
ardised tool for use as a measure of health outcome 
applicable to a wide range of health conditions that pro-
vides a simple descriptive profile and a single index value 
for health status [24].
In addition, personal satisfaction with the lifestyle 
intervention and didactic materials will be evaluated 
using a 7-item specifically-designed questionnaire to be 
fulfilled both by the facilitators of the intervention and 
participants.
Programme sustainability
Analyzing proceedings is an essential element for evalu-
ating the entire DP-TRANSFERS programme. For this 
purpose there is provided a detailed review of the process 
in order to assess whether the actions are implemented 
as planned, achieves operational objectives and whether 
translation to primary care centres is really feasible. Run-
ning objectives and evaluation components (process 
indicators, outputs, outcomes, impact, timeframe and 
deliverables) are shown in Table 2.
Economic analysis
This translation programme is preceded by a confirma-
tory cost-effectiveness analysis [13]. Thus, the specific 
DE-PLAN-CAT approach for cost assessment will be 
also incorporated at least to calculate the average cost per 
participant in the DP-TRANSFERS programme as well as 
the economic burden that may represent spreading of the 
lifestyle intervention to all primary care centres. For the 
analysis of direct costs generated by the process and the 
intervention, the primary care centres will be requested 
to record data on resources used from the representa-
tive sample of the participant population whose eco-
nomic parameters form part of the follow-up and are also 
included in the eCRF.
Particular attention will be paid to the direct costs 
incurred during two periods and at two levels. The 
start-up period cost covers pre-implementation phase, 
planning, consensus meetings, training, printing and 
spreading didactic materials. These costs are spent only 
once for the organization. The post start-up period cost 
covers implementation and running the programme 
(screening, intensive intervention and continuous inter-
vention). Cost at management level consider resources 
used for coordinating of the intervention in each partici-
pating centre including planning, organizing and moni-
toring of the intervention and training of the personnel. 
Costs at participant level include all resources used at 
the point of delivery of the intervention such as: costs 
of screening, blood testing and didactic materials used. 
Changes in use of health services due to intervention will 
be also considered.
Organization, data collection and analysis
Organization
A multidisciplinary coordinating committee has been 
established to implement and coordinate the overall 
translation programme. Two representatives from each 
coordinating centre (nurse and general practitioner) will 
be invited to join the coordinating committee. Each of 
these reference centres would lead a local coordinating 
commission with representatives from their respective 
primary care associated centres, drawn out a tree struc-
ture. Every providing primary care centre is composed 
of many independent teams managing their own activity 
though coordinated at a centre level.
Data collection
Data will be collected and monitored electronically. Par-
ticipants will be assigned a unique number (lowest avail-
able number allocated to the site) which will remain the 
same throughout the programme. The Reus-Tarragona 
coordinating centre will provide, besides coordination 
and steering, methodological support and statistical 
data treatment. To assist data collection and subsequent 
global spread of this initiative, it was developed a web-
site-based eCRF (http://www.faqcil.com/crd/index.php). 
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The main advantages are: centralized data, easy access to 
the active participants, simple recording, and fast access 
to programme files, documents and didactic material for 
lifestyle intervention, fast internal messaging system and 
a convenient updated consultation at any time. Addition-
ally, it supports different user profiles, enables to backup 
data allowing confidentiality and multiplatform access.
Data will be directly collected by the associated investi-
gators and revised by an independent non-epidemiologist. 
To ensure quality and avoid discrepancies, files will be 
also reviewed by an expert epidemiologist if necessary. In 
case of data inconsistencies, the teams will be required to 
complete a “query–response” electronic form. Additional 
checking will be performed after entering the information 
to avoid inconsistencies due to any mistake in data input.
Analysis
Analysis at 12 and 24 months will determine the degree 
that translational programme objectives were achieved, 
through overall and sub-group testing. Multiple compari-
sons of significant differences among groups will be car-
ried out by one-way ANOVA and/or by Student’s t test. 
Participants who discontinued the programme will be 
considered to be at risk for diabetes until their last visit, 
at which point data will be censored. The level of statisti-
cal significance will be set as p < 0.05 for all analyses.
Primary outcomes which will be reported include 
changes in lifestyle habits as physical activity levels and 
dietary pattern (evaluated through programme question-
naires); clinical and anthropometric measurements (pos-
sible reduction in weight, waist circumference and blood 
pressure); biological measurements (with special empha-
sis on the potential reduction in diabetes incidence) and 
finally, personal satisfaction, psychological and quality 
of life measurements (evaluated through programme 
preference-based, health-related instruments). Regarding 
prefixed goals for lifestyle intervention, characteristics 
and proportions of the cohort achieving 1, 2, 3, 4 or all 
5 goals will be analyzed. Logistic regression analysis will 
be used to determine factors associated with the achieve-
ment of programme goals.
Process analyses which will be reported include 
detailed information on programme reliability and 
knowledge by staff, satisfaction of participants and facili-
tators as well as barriers associated with programme 
implementation and delivery (Table  2). Meanwhile, the 
economic analysis is not intended to confirm the eco-
nomic viability of the lifestyle intervention as it has 
already been demonstrated. The main purpose is to ana-
lyse the direct average cost per participant and then esti-
mate the overall cost of the translation process. Direct 
costs will be accounted for and measured according to 
reliable available rates in the Catalan health service which 
provides internal and external consistency. If feasible, a 
cost-utility analysis could be developed based on utility 
measures extracted from the EQ-5D-5L questionnaire 
to obtain the quality-adjusted life-year gained in lifestyle 
intervention.
Discussion and points of interest
Transferring sustainable and effective lifestyle interven-
tion to society remains the major challenge of scientific 
research in the field of diabetes prevention. A recent 
survey estimated that about 21 % of Spanish adult popu-
lation could be classified as having undiagnosed predia-
betes or Type 2 diabetes [25]. Therefore, a large group of 
middle-aged individuals could benefit from this proposal. 
It was recently found that three out of four potential 
users of public health services have made a consultation 
to the primary care team at least once a year [16]. Thus, 
the present translational programme will use a strategy 
of approach to society consistent with both the impact 
of the disease and the fast accessibility to health services 
provided by primary care settings in Catalonia.
The findings from the European DE-PLAN-CAT pro-
ject should support the conclusion that intervention 
programmes that have been developed and scientifically 
tested, not only by academic clinical trials but by primary 
care implementations must be recognised as the standard 
evidence-based healthcare. The DP-TRANSFERS pro-
posal aims to utilize our experience from clinical studies, 
implementation initiatives and development projects, to 
build up, test, disseminate and promote the uptake of a 
new nationwide translational programme. Even more, all 
these transfers’ actions are aimed at efficient prevention 
of diabetes, in people most at risk, from the perspective 
of the provider of public health services. Consequently, 
it would be helpful that consistent preventive measures 
should be properly planned [26].
Assuming that the programme reaches a truly opera-
tional screening loop, the final success mainly depends 
on ensuring a strong lifestyle intervention [27]. It has 
been documented that determinants of success are pre-
cisely related to a long duration of the first step (basic 
module) and then a sustained effect of the subsequent 
reinforcement (continuity module) [28]. In any case, this 
is one of the first attempts to assess a transfer mechanism 
to extend a lifestyle intervention to prevent Type 2 dia-
betes at a national level through a community-wide real-
life programme agreed with all primary care centres, an 
aspect on which there is almost no scientific information 
available.
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